| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680008 | Alzheimer's & Dementia | 2018 | 9 Pages |
Abstract
Because large numbers of persons are living with preclinical AD, our results underscore the need for secondary preventions for persons with existing AD brain pathology who are likely to develop clinical disease during their lifetimes as well as primary preventions for persons without preclinical disease.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ron Brookmeyer, Nada Abdalla, Claudia H. Kawas, MarÃa M. Corrada,